Revance Therapeutics Statistics
Total Valuation
Five9 has a market cap or net worth of EUR 1.62 billion. The enterprise value is 1.77 billion.
Market Cap | 1.62B |
Enterprise Value | 1.77B |
Important Dates
The next estimated earnings date is Thursday, August 7, 2025.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 77.26M |
Shares Outstanding | n/a |
Shares Change (YoY) | +3.46% |
Shares Change (QoQ) | +0.71% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 74.78M |
Valuation Ratios
The trailing PE ratio is 216.14 and the forward PE ratio is 7.98.
PE Ratio | 216.14 |
Forward PE | 7.98 |
PS Ratio | 1.73 |
PB Ratio | 2.66 |
P/TBV Ratio | 6.52 |
P/FCF Ratio | 13.39 |
P/OCF Ratio | 10.94 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.29, with an EV/FCF ratio of 14.56.
EV / Earnings | 235.00 |
EV / Sales | 1.84 |
EV / EBITDA | 24.29 |
EV / EBIT | 150.67 |
EV / FCF | 14.56 |
Financial Position
The company has a current ratio of 4.44, with a Debt / Equity ratio of 1.11.
Current Ratio | 4.44 |
Quick Ratio | 3.80 |
Debt / Equity | 1.11 |
Debt / EBITDA | 9.52 |
Debt / FCF | 5.61 |
Interest Coverage | 0.83 |
Financial Efficiency
Return on equity (ROE) is 1.42% and return on invested capital (ROIC) is 0.52%.
Return on Equity (ROE) | 1.42% |
Return on Assets (ROA) | 0.47% |
Return on Invested Capital (ROIC) | 0.52% |
Return on Capital Employed (ROCE) | 0.90% |
Revenue Per Employee | 306,411 |
Profits Per Employee | 2,446 |
Employee Count | 3,073 |
Asset Turnover | 0.61 |
Inventory Turnover | n/a |
Taxes
Income Tax | -2.32M |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 23.42 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 26.18 |
Average Volume (20 Days) | 30 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Five9 had revenue of EUR 941.60 million and earned 7.52 million in profits. Earnings per share was 0.09.
Revenue | 941.60M |
Gross Profit | 520.59M |
Operating Income | 11.53M |
Pretax Income | 5.19M |
Net Income | 7.52M |
EBITDA | 60.00M |
EBIT | 11.53M |
Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 541.45 million in cash and 680.78 million in debt, giving a net cash position of -139.33 million.
Cash & Cash Equivalents | 541.45M |
Total Debt | 680.78M |
Net Cash | -139.33M |
Net Cash Per Share | n/a |
Equity (Book Value) | 610.85M |
Book Value Per Share | 7.91 |
Working Capital | 589.75M |
Cash Flow
In the last 12 months, operating cash flow was 148.49 million and capital expenditures -27.15 million, giving a free cash flow of 121.34 million.
Operating Cash Flow | 148.49M |
Capital Expenditures | -27.15M |
Free Cash Flow | 121.34M |
FCF Per Share | n/a |
Margins
Gross margin is 55.29%, with operating and profit margins of 1.22% and 0.80%.
Gross Margin | 55.29% |
Operating Margin | 1.22% |
Pretax Margin | 0.55% |
Profit Margin | 0.80% |
EBITDA Margin | 6.37% |
EBIT Margin | 1.22% |
FCF Margin | 12.89% |
Dividends & Yields
Five9 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.46% |
Shareholder Yield | n/a |
Earnings Yield | 0.46% |
FCF Yield | 7.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 7 |